Trial Profile
Metabolite Profile, Excretion Balance and Pharmacokinetics of BI 207127 NA Combined With [14C]-BI 207127 NA in Healthy Adult Male Volunteers After an 800 mg Single Oral Solution Dose; a Phase I, Single-arm, Open-label Trial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2016
Price :
$35
*
At a glance
- Drugs Deleobuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 30 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 May 2012 New trial record